Oruka Therapeutics Inc (ORKA)

Jul 23, 2025

What drives Oruka Therapeutics Inc. stock priceOverwhelming financial success - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is Oruka Therapeutics Inc. a good long term investmentAccelerated investment success - Autocar Professional

Jul 23, 2025

Jul 23, 2025

H.C. Wainwright reiterates Buy rating on Oruka Therapeutics stock as FDA clears IND - Investing.com Canada

Jul 23, 2025

Jul 23, 2025

Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN

Jul 23, 2025

Jul 23, 2025

Oruka Therapeutics Inc. Stock Analysis and ForecastMassive profits - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Oruka Therapeutics Inc. stockExponential return rates - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

Wedbush Reiterates Outperform Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Jul 23, 2025

Jul 22, 2025

Oruka Therapeutics Announces IND Clearance for EVERLAST-A - GlobeNewswire

Jul 22, 2025

Jul 21, 2025

Oruka Therapeutics stock rises after FDA clears IND for psoriasis drug - Investing.com India

Jul 21, 2025

Jul 21, 2025

Stifel reiterates Buy rating on Oruka Therapeutics stock with $47 target - Investing.com Canada

Jul 21, 2025

Jul 21, 2025

Oruka Therapeutics: Revolutionizing Psoriasis Treatment with Extended-Dosing Biologics - AInvest

Jul 21, 2025

Jul 21, 2025

FDA clears Oruka’s IND for psoriasis drug ORKA-001 phase 2a trial - Investing.com India

Jul 21, 2025

Jul 21, 2025

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September - Yahoo Finance

Jul 21, 2025

Jul 18, 2025

How high can Oruka Therapeutics Inc. stock price go in 2025Balanced Risk Reward Portfolio - Newser

Jul 18, 2025

Jul 15, 2025

How Oruka Therapeutics Inc. stock performs during market volatilityDaily Volume Leaders - Newser

Jul 15, 2025

Jul 15, 2025

Why Oruka Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser

Jul 15, 2025

Jul 15, 2025

What makes Oruka Therapeutics Inc. stock price move sharplyWeekly Big Movers - Newser

Jul 15, 2025

Jul 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jul 15, 2025

Jul 04, 2025

Oruka Therapeutics announces COO appointment - MSN

Jul 04, 2025

Jul 02, 2025

Oruka Therapeutics Shares Soar 16.1% on Executive Promotion, Index Inclusion - AInvest

Jul 02, 2025

Jul 01, 2025

Oruka Therapeutics Promotes Laura Sandler to COO - MarketScreener

Jul 01, 2025

Jul 01, 2025

Oruka Therapeutics promotes Laura Sandler to chief operating officer - Investing.com

Jul 01, 2025

Jul 01, 2025

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer - GlobeNewswire

Jul 01, 2025

Jul 01, 2025

Oruka Therapeutics Appoints New Chief Operating Officer - TipRanks

Jul 01, 2025

Jun 29, 2025

Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 3000E Index - MarketScreener

Jun 29, 2025

Jun 20, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Recommendation of “Buy” by Analysts - Defense World

Jun 20, 2025